General
Preferred name
NS 11394
Synonyms
NS11394 ()
NSD-721 (disputed) ()
NS-11394 ()
P&D ID
PD013032
CAS
951650-22-9
Tags
available
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION NS 11394 is a drug with selectivity for the α3 and α5 subtypes. It acts as a subtype-selective positive allosteric modulator at GABAA receptors. It is used as an analgesic for use in chronic or neuropathic pain. It is unique in having superior efficacy at alpha(3) receptors and low efficacy at alpha(1) receptors in vitro. It has an excellent pharmacokinetic profile, which correlates with pharmacodynamic endpoints, yielding a high level of confidence in deriving in vivo conclusions anchored to an in vitro selectivity profile and allowing for translation to higher species. It impairs memory in both rats and mice because of its efficacy at GABA(A)-alpha(5) receptors. It is potent and highly effective in rodent anxiety models. It has a significantly reduced side effect profile in rat and mouse, even at full CNS receptor occupancy. (BOC Sciences Bioactive Compounds)
Compound Sets
7
Axon Medchem Screening Library
1457
BOC Sciences Bioactive Compounds
ns-11394-cas-951650-22-9-item-460923
Cayman Chemical Bioactives
23872
Drug Repurposing Hub
MedChem Express Bioactive Compound Library
HY-11048
ReFrame library
TargetMol Bioactive Compound Library
T2067
External IDs
16
Properties
(calculated by RDKit )
Molecular Weight
353.15
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
4
Aromatic Ring Count
4
cLogP
4.79
TPSA
61.84
Fraction CSP3
0.13
Chiral centers
0.0
Largest ring
6.0
QED
0.58
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Membrane Transporter/Ion Channel
Neuroscience
Neuronal Signaling
Target
GABAA
GABAA PAM
GABA Receptor
MOA
GABA Receptor agonist
Solubility
DMSO: ≥ 43 mg/mL
Source data